In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.

作者信息

Compain Fabrice, Botterel Françoise, Sitterlé Emilie, Paugam André, Bougnoux Marie-Elisabeth, Dannaoui Eric

机构信息

Université Paris-Descartes, Faculté de Médecine, APHP, Hôpital Européen Georges Pompidou, Unité de Parasitologie-Mycologie, Service de Microbiologie, Paris, France.

Dynamyc Research Group, Université Paris-Est Créteil, Faculté de Médecine, Créteil, France.

出版信息

J Med Microbiol. 2015 Mar;64(Pt 3):309-311. doi: 10.1099/jmm.0.000019. Epub 2015 Jan 16.

DOI:10.1099/jmm.0.000019

PMID:25596124

Abstract

摘要

相似文献

In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.

J Med Microbiol. 2015 Mar;64(Pt 3):309-311. doi: 10.1099/jmm.0.000019. Epub 2015 Jan 16.

In vitro combination of voriconazole and miltefosine against clinically relevant molds.伏立康唑与米替福新针对临床相关霉菌的体外联合应用

Antimicrob Agents Chemother. 2014 Nov;58(11):6996-8. doi: 10.1128/AAC.03212-14. Epub 2014 Sep 8.

In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.米替福新作为单一药物以及与伏立康唑或泊沙康唑联合使用对罕见丝状真菌病原体的体外活性。

J Antimicrob Chemother. 2013 Dec;68(12):2842-6. doi: 10.1093/jac/dkt282. Epub 2013 Jul 16.

In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.多黏菌素单药及联合抗真菌药物对囊性纤维化患者肺部丝状真菌的体外活性。

Mycoses. 2013 May;56(3):297-303. doi: 10.1111/myc.12022. Epub 2012 Nov 22.

In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.两性霉素B与米卡芬净对赛多孢菌属的体外协同相互作用

Antimicrob Agents Chemother. 2005 Aug;49(8):3498-500. doi: 10.1128/AAC.49.8.3498-3500.2005.

In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates.雷夫康唑对接合菌、头孢霉和镰刀菌分离株的体外活性。

Clin Microbiol Infect. 2003 Dec;9(12):1250-2. doi: 10.1111/j.1469-0691.2003.00755.x.

Antifungal Susceptibility of the Emerging Multidrug-Resistant Pathogen Candida auris to Miltefosine Alone and in Combination with Amphotericin B.新兴多重耐药病原体耳念珠菌对米替福新单药及与两性霉素B联合使用的抗真菌药敏性

Antimicrob Agents Chemother. 2020 Jan 27;64(2). doi: 10.1128/AAC.02063-19.

In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.伏立康唑、伊曲康唑和两性霉素B对机会性念珠菌和暗色真菌的体外杀真菌活性。

J Clin Microbiol. 2001 Mar;39(3):954-8. doi: 10.1128/JCM.39.3.954-958.2001.

Effects of Photodynamic Therapy on the Growth and Antifungal Susceptibility of Scedosporium and Lomentospora spp.光动力疗法对拟青霉属和枝孢属生长和抗真菌敏感性的影响。

Mycopathologia. 2017 Dec;182(11-12):1037-1043. doi: 10.1007/s11046-017-0195-8. Epub 2017 Aug 23.

In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.两性霉素B、伊曲康唑和伏立康唑对曲霉属、镰刀菌属和赛多孢菌属的体外药效学

Antimicrob Agents Chemother. 2005 Mar;49(3):945-51. doi: 10.1128/AAC.49.3.945-951.2005.

引用本文的文献

Targeting fungal lipid synthesis for antifungal drug development and potentiation of contemporary antifungals.以真菌脂质合成作为抗真菌药物研发及增强现有抗真菌药物效果的靶点。

NPJ Antimicrob Resist. 2025 Apr 12;3(1):27. doi: 10.1038/s44259-025-00093-4.

Cerebral abscesses due to Pseudallescheria boydii mycoses: a diagnostic and therapeutic conundrum.波氏假阿利什利霉真菌病所致脑脓肿：诊断与治疗难题

Acta Neurol Belg. 2025 Feb;125(1):243-246. doi: 10.1007/s13760-024-02661-3. Epub 2024 Oct 22.

Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections.鞘内孢子菌病和节孢子菌病：这些难以治疗的罕见霉菌感染的现代观点。

Clin Microbiol Rev. 2024 Jun 13;37(2):e0000423. doi: 10.1128/cmr.00004-23. Epub 2024 Mar 29.

Miltefosine: A Repurposing Drug against Mucorales Pathogens.米替福新：一种用于治疗毛霉目病原体的重新利用药物。

J Fungi (Basel). 2023 Dec 4;9(12):1166. doi: 10.3390/jof9121166.

Oral delivery of brain-targeted miltefosine-loaded alginate nanoparticles functionalized with polysorbate 80 for the treatment of cryptococcal meningitis.口服载米替福新的海藻酸钠纳米粒，用聚山梨酯 80 修饰，用于治疗隐球菌性脑膜炎。

J Antimicrob Chemother. 2023 Apr 3;78(4):1092-1101. doi: 10.1093/jac/dkad053.

Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine.筛选化学文库以寻找针对烟曲霉的新型抗真菌药物，揭示了神经鞘脂类参与米替福新的作用机制。

mBio. 2021 Aug 31;12(4):e0145821. doi: 10.1128/mBio.01458-21. Epub 2021 Aug 10.

Miltefosine Against and Species: Antifungal Activity and Its Effects on Fungal Cells.米替福新抗和种属：抗真菌活性及其对真菌细胞的影响。

Front Cell Infect Microbiol. 2021 Jul 23;11:698662. doi: 10.3389/fcimb.2021.698662. eCollection 2021.

Techniques for the Assessment of In Vitro and In Vivo Antifungal Combinations.体外和体内抗真菌联合用药评估技术

J Fungi (Basel). 2021 Feb 4;7(2):113. doi: 10.3390/jof7020113.

Antifungal Susceptibility Profiles and Drug Resistance Mechanisms of Clinical Lomentospora prolificans Isolates.临床多育卷枝毛霉分离株的抗真菌药敏谱及耐药机制

Antimicrob Agents Chemother. 2020 Oct 20;64(11). doi: 10.1128/AAC.00318-20.

Investigation of a case cluster with whole genome sequencing.通过全基因组测序对一个病例集群进行调查。

Med Mycol Case Rep. 2020 May 19;29:1-4. doi: 10.1016/j.mmcr.2020.05.003. eCollection 2020 Sep.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验